# Evaluation of the Prognostic Value of the Suppression Ratio Evaluated by BIS Among Patients Admitted to the ICU for Cardiac Arrest

Study · id `cardio:ct-nct02869997` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02869997](<https://clinicaltrials.gov/study/NCT02869997>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02869997

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 102 participants.

## Technical summary

Registry record NCT02869997. Allocation not applicable; no masking; primary purpose diagnostic. Start 2012-08 (registry gives no type); primary completion 2014-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 102 participants (enrolled count; ClinicalTrials.gov record NCT02869997, source copy `cardio:ctgov-nct02869997-2016-08-17`, retrieved 2026-10-26)
- Start date: 2012-08 (registry gives no type) (ClinicalTrials.gov record NCT02869997, source copy `cardio:ctgov-nct02869997-2016-08-17`, retrieved 2026-10-26)
- Primary completion: 2014-09 (actual) (ClinicalTrials.gov record NCT02869997, source copy `cardio:ctgov-nct02869997-2016-08-17`, retrieved 2026-10-26)
- Completion: 2017-05 (anticipated) (ClinicalTrials.gov record NCT02869997, source copy `cardio:ctgov-nct02869997-2016-08-17`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02869997, source copy `cardio:ctgov-nct02869997-2016-08-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02869997-2016-08-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of the Prognostic Value of the Suppression Ratio Evaluated by BIS Among Patients Admitted to the ICU for Cardiac Arrest
- Acronym: SACRE
- Condition: Cardiac Arrest
- Intervention (Device): Aspect BIS XP (A-2000) Bispectral Index Patient Monitor
- Lead sponsor: Centre Hospitalier Universitaire de Besancon
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Centre Hospitalier Universitaire de Besancon (`cardio:org-centre-hospitalier-universitaire-de-besancon`)

## Provenance

Content hash: 6f02440f247ed8360ccb0fd1edbab2bebcbb7c4ea1be38a60d492907537662f0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
